Giving clinical significance to molecular targets.
TriStar Tissue Micro Arrays enable the simultaneous analysis of thousands of human tissue samples in a single experiment under uniform conditions.
References
Moch H., Kononen J., Kallioniemi O. P., and Sauter G. 2001. Tissue Microarrays: What will they bring to molecular and anatomic pathology? Advances in Anatomic Pathology. Vol 8, No. 1 pp 14-20.
Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M. J., Sauter G., and Kallioniemi O. P. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine. Vol. 4 No. 7 pp 844-847.
Moch H., Schrami P., Bubendorf L., Mirlacher M., Kononen J., Gasser T., Mihatsch M. J., Kallioniemi O. P., and Sauter G. 1999. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. American Journal of Pathology. Vol. 154 No. 4 pp 981-986.
Richter J., Wagner U., Kononen J., Fijan A., Bruderer J., Schmid U., Ackermann D., Maurer R., Alund A, et al. 2000. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. American Journal of Pathology. Vol. 157. No. 3 pp 787-794.
Bubendorf L., Kononen J., Koivisto P., Schrami P, et al. 1999. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Research. Vol. 59 pp 803-806.
Jacobs T.W.,Prioleau J.E., Stillman I.E and Schnitt S.J. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. Journal of the National Cancer Institute, Vol 88 pp 1054-1059.